Skip to main content
Total Market Cap: $93,365,888,912 Volume (24h): $4,809,978,213

Cara Therapeutics Inc.

Cara Therapeutics Inc. (CARA) logo
Rank 17
About

Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.

Website
$18.5600
USD
2.83%
Market cap
$861,512,512
Total volume
$9,724,363
Shares outstanding
46,417,700
Rank 17
Website
About

Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
Nasdaq
CARA
$9,724,363
100%
$18.5600
Chart
Social media

Share widget

Copy widget code
Subscribe to our newsletter